APTEGRA Trademark

Trademark Overview


On Wednesday, October 11, 2023, a trademark application was filed for APTEGRA with the United States Patent and Trademark Office. The USPTO has given the APTEGRA trademark a serial number of 79382926. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 10, 2024. This trademark is owned by Merck KGaA. The APTEGRA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research, clinical research in the field of pharmaceuticals, and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for pharmaceutical products for others; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development serv...
aptegra

General Information


Serial Number79382926
Word MarkAPTEGRA
Filing DateWednesday, October 11, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 10, 2024

Trademark Statements


Goods and ServicesBiological research, clinical research in the field of pharmaceuticals, and medical research; scientific research; pharmaceutical research and development; preparation of reports relating to scientific research; research and development services in the field of antibodies; research and testing services in the fields of bacteriology and virology; research and development of vaccines and medicines; development of pharmaceutical preparations and medicines; Scientific research in the nature of conducting clinical trials for pharmaceutical products for others; consultancy relating to pharmaceutical research and development; preparation of scientific reports; conducting of scientific studies in the field of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; advisory services relating to scientific research; pharmaceutical product evaluation; genetic testing for scientific research purposes; research and development services in the field of gene therapy; product quality and safety testing services in the field of antibodies; product quality and safety testing services for vaccines and medicines; research and development in the field of cell therapies; product quality and safety testing services for gene or cell therapies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, November 9, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 21, 2023ASSIGNED TO EXAMINER
Saturday, January 20, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 7, 2024REFUSAL PROCESSED BY MPU
Wednesday, February 7, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 7, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, February 7, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 7, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 7, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 7, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, November 18, 2023APPLICATION FILING RECEIPT MAILED
Friday, January 19, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 7, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 27, 2024REFUSAL PROCESSED BY IB
Wednesday, June 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 2, 2024ASSIGNED TO EXAMINER
Wednesday, August 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 10, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED